Zero tariffs for UK drug exports to US, but experts warn deal will cost NHS billions

Some patients will benefit from improved access to expensive drugs as a result of the US-UK trade deal which came into effect this month, but experts warn it will cost the NHS billions and not benefit UK patients as a whole.